López J, Fernández Villalta M J, de la Calle C, Biurrum M, Gómez-Reino F, Fernández-Rañada J M
Servicio de Hematología, Hospital de la Princesa, Madrid.
Sangre (Barc). 1990 Feb;35(1):15-7.
Routine performance of the direct antiglobulin test (DAT) in pretransfusion testing (PT) is controversial. To evaluate its usefulness, we review the positive DATs found in 22,517 PT performed in our center in the last five years. DAT was positive in 330 PT (1.4%). Eluate studies gave information, not obtained from the rest of PT, in 6 cases. DAT predictive value is low (1.8% of the positive DATs, 0.02% of all PT). Although this predictive value is low, we keep on follow including DAT in PT but we have reduced eluate studies to 1) positive DAT of untransfused patients (to get information of the DAT prior to transfusion and to detected autoimmune haemolytic anaemias) and 2) positive DAT of previously transfused patients with previous negative DAT or changes in its reactivity (for the prompt detection of clinically significant antibodies).
在输血前检测(PT)中常规进行直接抗球蛋白试验(DAT)存在争议。为评估其效用,我们回顾了过去五年在本中心进行的22517次PT中发现的阳性DAT结果。在330次PT(1.4%)中DAT呈阳性。洗脱液研究在6例病例中提供了从其他PT中未获得的信息。DAT的预测价值较低(阳性DAT的1.8%,所有PT的0.02%)。尽管该预测价值较低,但我们仍继续在PT中进行DAT检测,但已将洗脱液研究减少至:1)未输血患者的阳性DAT(以获取输血前DAT的信息并检测自身免疫性溶血性贫血);2)既往DAT阴性或反应性改变的既往输血患者的阳性DAT(以便及时检测具有临床意义的抗体)。